| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/04/2009 | EP2030981A1 Compounds for proteasome enzyme inhibition |
| 03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
| 03/04/2009 | EP1635816B1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 03/04/2009 | EP1515984B1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1064300B1 Peptide turn mimetics |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101379077A Small peptidic and peptido-mimetic affinity ligands for factor VIII and factor VIII-like proteins |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498405 Halogen-substituted thienyl compounds |
| 03/03/2009 | US7498310 Applying a water in oil emulsion of a tetrapeptide: H2N-Valine-Valine-Arginine-Proline or one of its amide derivatives |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498025 Targeted bifunctional molecules and therapies based thereon |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/25/2009 | EP2028191A1 Peptides and compounds that bind to a receptor |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2028185A1 Tubulysin and tubulysin agent |
| 02/25/2009 | EP2027152A2 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 02/25/2009 | EP2027144A1 Macrocyclic compounds as antiviral agents |
| 02/25/2009 | EP2027143A2 Compounds and compositions as channel activating protease inhibitors |
| 02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
| 02/25/2009 | CN101374856A Inhibiting tumor cell invasion, metastasis and angiogenesis |
| 02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/25/2009 | CN100463901C Alpha-ketoamide derivative, and production method and use thereof |
| 02/24/2009 | US7495083 PRO940 antibodies |
| 02/24/2009 | US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/19/2009 | WO2009022182A1 Depsipeptide derivatives and their therapeutic use |
| 02/19/2009 | WO2009009378A3 Cathepsin-d neuroprotection |
| 02/19/2009 | WO2008144747A3 Lipoproteins, lipopeptides and analogs, and methods for making and using them |
| 02/19/2009 | WO2008142517A3 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 02/19/2009 | WO2008118332A3 Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090047711 Bis-sulfhydryl macrocyclization systems |
| 02/19/2009 | US20090047654 Polymer affinity matrix, a method for the production and use thereof |
| 02/18/2009 | EP2025681A2 Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
| 02/18/2009 | EP2024388A1 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application |
| 02/18/2009 | EP2024387A1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application |
| 02/18/2009 | EP1629000B1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | CN101370820A Compounds for the inhibition of apoptosis |
| 02/18/2009 | CN100462370C Process for purifying interferon beta |
| 02/17/2009 | US7491795 Neuropeptides and their use for pest control |
| 02/17/2009 | US7491793 Influenza virus inhibiting peptides |
| 02/17/2009 | US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma |
| 02/17/2009 | US7491704 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 02/17/2009 | US7491703 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 02/17/2009 | US7491702 X1-Ser-Met-Arg-Glu-Arg-X2 in which X1 and X2 are up to 30 amino acid residues and the formula represents a reverse-order sequence corresponding to amino acid residues 332 to 328 of human APP and from zero to 30 successive amino acid residues |
| 02/17/2009 | US7491699 Peptide nanostructures and methods of generating and using the same |
| 02/17/2009 | US7491695 Methods of using macrocyclic modulators of the ghrelin receptor |
| 02/17/2009 | US7491691 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants |
| 02/17/2009 | US7491690 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 02/17/2009 | US7491689 Compositions comprising the biologically active peptide YSL |
| 02/12/2009 | WO2009020448A1 Proteasome inhibitors |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | US20090042809 Blood Pressure Lowering Protein Hydrolysates |
| 02/12/2009 | US20090042244 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 02/12/2009 | US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 02/12/2009 | CA2695877A1 Novel .gamma.-secretase inhibitor |
| 02/12/2009 | CA2695082A1 Peptide boronic acid and boronic ester compounds as proteasome inhibitors |
| 02/12/2009 | CA2663580A1 Bioactive peptides and method of using same |
| 02/11/2009 | EP2021500A2 Selective modulation of receptor signalling |
| 02/11/2009 | EP2021364A1 Improved antimicrobial peptides |
| 02/11/2009 | EP2021353A2 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application |
| 02/11/2009 | EP2021334A1 Synthesis and uses of pyroglutamic acid derivatives |
| 02/11/2009 | EP1458747B1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 02/11/2009 | CN101362793A Prodrugs of excitatory amino acids |
| 02/11/2009 | CN100460382C Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
| 02/10/2009 | US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof |
| 02/10/2009 | US7488792 Peptides; antitumor agents; anticancer agents |
| 02/10/2009 | US7488713 Cancer treatment using C-type natriuretic peptides |
| 02/10/2009 | US7488712 Histone deacetylase inhibitors and methods for producing the same |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/05/2009 | WO2009018493A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | WO2009017154A1 Method for producing peptide |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | US20090035272 Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | DE102007036076A1 Dipeptoid-Produgs und ihre Verwendung Dipeptoid prodrugs and their use |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2694930A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | CA2694542A1 Method for producing peptide |
| 02/05/2009 | CA2692847A1 Methods of inhibiting calcineurin with apoe analogs |
| 02/04/2009 | EP2019837A1 Compounds and compositions as channel activating protease inhibitors |
| 02/04/2009 | EP2019819A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/03/2009 | US7485777 Introducing nucleotide sequence into a plant cell encoding a variant of algae protoporphyrinogen IX oxidase that lacks the FAD binding sequence; nucleotide sequence is expressed and plant cell is regenerated into transgenic plant; transformation |
| 02/03/2009 | US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | CA2423916C Compounds with a branched linker |
| 01/29/2009 | WO2009012958A2 Tubulysin d analogues |
| 01/29/2009 | WO2008070049A3 Peptide and treatment for hiv-1 infection |
| 01/29/2009 | WO2006045066A9 Labeled compounds for proteasome inhibition |
| 01/29/2009 | US20090030181 Peptides for Inhibiting MDM2 Function |
| 01/29/2009 | US20090029926 Lys-thr dipeptides and their use |
| 01/29/2009 | US20090028813 Methods for Treating Body Tissue |